VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $554 | -32.8% | 128,330 | +2.6% | 0.00% | -100.0% |
| Q2 2023 | $824 | +20.8% | 125,065 | +24.7% | 0.00% | – |
| Q1 2023 | $682 | -4.7% | 100,294 | +3.7% | 0.00% | – |
| Q4 2022 | $716 | -99.9% | 96,744 | -2.6% | 0.00% | -100.0% |
| Q3 2022 | $981,000 | +393.0% | 99,302 | +443.9% | 0.00% | – |
| Q2 2022 | $199,000 | -60.7% | 18,258 | -59.2% | 0.00% | – |
| Q1 2022 | $507,000 | -77.4% | 44,769 | -68.8% | 0.00% | – |
| Q4 2021 | $2,248,000 | +130.8% | 143,282 | +152.2% | 0.00% | – |
| Q3 2021 | $974,000 | +33.6% | 56,802 | +67.6% | 0.00% | – |
| Q2 2021 | $729,000 | -50.3% | 33,890 | -65.3% | 0.00% | -100.0% |
| Q1 2021 | $1,467,000 | +35.5% | 97,698 | +18.6% | 0.00% | 0.0% |
| Q4 2020 | $1,083,000 | +4.6% | 82,389 | -23.2% | 0.00% | 0.0% |
| Q3 2020 | $1,035,000 | -6.7% | 107,309 | +10.6% | 0.00% | 0.0% |
| Q2 2020 | $1,109,000 | +45.9% | 97,039 | +32.3% | 0.00% | 0.0% |
| Q1 2020 | $760,000 | -48.4% | 73,349 | -18.3% | 0.00% | 0.0% |
| Q4 2019 | $1,473,000 | +43.6% | 89,791 | +16.2% | 0.00% | 0.0% |
| Q3 2019 | $1,026,000 | -19.6% | 77,276 | -14.7% | 0.00% | 0.0% |
| Q2 2019 | $1,276,000 | +2.7% | 90,617 | +34.3% | 0.00% | 0.0% |
| Q1 2019 | $1,243,000 | +100.5% | 67,489 | +184.3% | 0.00% | – |
| Q4 2018 | $620,000 | -59.2% | 23,735 | -64.2% | 0.00% | -100.0% |
| Q3 2018 | $1,520,000 | +1087.5% | 66,232 | +888.4% | 0.00% | – |
| Q2 2018 | $128,000 | -72.9% | 6,701 | -76.1% | 0.00% | – |
| Q1 2018 | $472,000 | +65.0% | 28,048 | +48.8% | 0.00% | – |
| Q4 2017 | $286,000 | -71.9% | 18,848 | -66.8% | 0.00% | -100.0% |
| Q3 2017 | $1,016,000 | +217.5% | 56,788 | +190.9% | 0.00% | – |
| Q2 2017 | $320,000 | -43.7% | 19,522 | -52.0% | 0.00% | -100.0% |
| Q1 2017 | $568,000 | +3.5% | 40,629 | +17.8% | 0.00% | – |
| Q4 2016 | $549,000 | -24.1% | 34,494 | -20.4% | 0.00% | – |
| Q3 2016 | $723,000 | +369.5% | 43,358 | +215.1% | 0.00% | – |
| Q2 2016 | $154,000 | +148.4% | 13,759 | +76.7% | 0.00% | – |
| Q1 2016 | $62,000 | -85.3% | 7,787 | -83.4% | 0.00% | – |
| Q4 2015 | $422,000 | -24.1% | 46,988 | -7.1% | 0.00% | – |
| Q3 2015 | $556,000 | -15.6% | 50,571 | -7.8% | 0.00% | – |
| Q2 2015 | $659,000 | -59.4% | 54,868 | -69.6% | 0.00% | -100.0% |
| Q1 2015 | $1,622,000 | -87.4% | 180,352 | -80.4% | 0.00% | -91.7% |
| Q4 2014 | $12,886,000 | +6611.5% | 920,452 | +4731.8% | 0.01% | – |
| Q3 2014 | $192,000 | -85.5% | 19,050 | -77.0% | 0.00% | -100.0% |
| Q2 2014 | $1,327,000 | -23.9% | 82,957 | -23.9% | 0.00% | 0.0% |
| Q1 2014 | $1,744,000 | -72.8% | 108,969 | -79.6% | 0.00% | -71.4% |
| Q4 2013 | $6,419,000 | +200.1% | 535,038 | +150.1% | 0.01% | +133.3% |
| Q3 2013 | $2,139,000 | -29.7% | 213,896 | -43.2% | 0.00% | -25.0% |
| Q2 2013 | $3,041,000 | – | 376,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |